Breaking News Instant updates and real-time market news.

2017-09-13 15:05:29

B

Barnes Group

$64.56

0.28 (0.44%)

15:05

09/13/17

09/13

15:05

09/13/17

15:05

Thomas Barnes reports 5.62% stake in Barnes Group

To the knowledge of Thomas Barnes, as of July 26,, there were 53,837,680 shares of common stock of Barnes Group as set forth in the Form 10-Q for the quarter ended June 30. Thomas Barnes beneficially owned as of the date of this report 3,023,996 shares of common stock of the company, representing 5.62% of the outstanding Common Stock. As of September 12, Thomas Barnes has the sole power to vote or to direct the vote of 3,023,996 shares, sole power to dispose of 931,984 shares, and shared power to direct the disposition of 2,092,012 shares of Common Stock. On August 10, Thomas Barnes sold 2,000 shares of Common Stock on the New York Stock Exchange at a price of $59.93 per share. Thomas Barnes received $119,860 as a result of the sale.

19

Sep

04

May

BBarnes Group

$64.56

0.28 (0.44%)

01/19/17

RHCO

01/19/17INITIATIONRHCOHold

Barnes Group initiated with a Hold at SunTrust

SunTrust analyst Michael Ciarmoli started coverage of Barnes Group with a $49 price target and a Hold rating.

04/04/17

JEFF

04/04/17NO CHANGETarget $57JEFFBuy

Barnes Group price target raised to $57 from $46 at Jefferies

Jefferies analyst Bhupender Bohra raised his price target for Barnes Group to $57 saying the company's "portfolio transformation story is coming along well." The analyst sees Barnes' earnings profile improving and he keeps a Buy rating on the shares.

04/24/17

SIDC

04/24/17DOWNGRADESIDCNeutral

Barnes Group downgraded to Neutral from Buy at Sidoti

07/31/17

OPCO

07/31/17NO CHANGETarget $67OPCOOutperform

Barnes Group price target raised to $67 from $58 at Oppenheimer

Oppenheimer analyst Christopher Glynn raised his price target for Barnes Group to $67 from $58 as organic momentum "surged," with short-term Industrial operating inefficiencies neutralizing the impact, and tax benefit defining the EPS guidance raise. He reiterates an Outperform rating on the shares.

UP AFTER EARNINGS: Cintas (CTAS), up 2.9%... Micron (MU), up 2.8%. ALSO HIGHER: Editas Medicine (EDIT), up 3.1% after it received the EMA's orphan medicinal product designation for EDIT-101... Twitter (TWTR), up 1.8% after it said it will start testing longer, 280-character tweets with a small group. DOWN AFTER EARNINGS: Nike (NKE), down 3.2%. ALSO LOWER: Kornit Digital (KRNT), down 12.2% after it cut its third quarter revenue guidance... Westlake Chemical Partners (WLKP), down 8.3% after it filed to sell 4.5M units for limited partners... Intra-Cellular (ITCI), down 7.2% after it filed to sell $150M in common stock... Ascendis Pharma (ASND), down 4.3% after it announced an offering of $125M of ADSs.